Research into areas like cancer could become collateral damage of a broader anti-mRNA push, according to a new study.

Add Yahoo as a preferred source to see more of our stories on Google. Health and Human Services Secretary Robert F. Kennedy Jr. said this week that he's pulling the plug on nearly $500 million in ...

RNA therapies present significant opportunities in targeting a broad range of diseases through various innovative approaches, including antisense oligonucleotides, siRNAs, mRNA vaccines, and aptamers.

A new method of making cancer cells more visible to the immune system could improve how well immunotherapy works against a ...

The messenger RNA (mRNA) market is undergoing significant expansion, driven by its versatile approach in treating and ...

Researchers led by Davide Incarnato at the University of Groningen have demonstrated that the FDA-approved cancer drug ...

Vivatides Therapeutics raises $54M to advance RNA therapies beyond the liver, targeting new disease areas and accelerating ...

Ribonucleic acids (RNAs) serve as messengers between DNA and protein production, and perform a wide variety of regulatory functions across different cellular processes. This makes them an interesting ...

A specific protein controls mRNA transport in fungi and distinguishes important from unimportant binding sites in the ...